Skip to main content

Table 2 Summarized pre- and post-BoNT-A median sPGE2-levels of OAB patients (Group 1, Group 1A = wet OAB, Group 1B = dry OAB)) and control group (Group 2) (f = female, m = male, y = years)

From: Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?

Group

sPGE2 pre [pg/ml]

Group

sPGE2 pre [pg/ml]

Group

sPGE2 [pg/ml]

1 (n = 56)

2749.5 (332–9422)

1A (n = 44)

3241 (389–9422)

1 (n = 30)

pre: 2995 (389–8861)

1B (n = 12)

1734 332–8861)

post: 1486 (201–11286)

2 (n = 31)

1674.3 (611–4038)

    

p-value

< 0.005

 

< 0.01

 

< 0.005